DE60202478D1 - Verfahren zur herstellung von polynukleotidvarianten - Google Patents

Verfahren zur herstellung von polynukleotidvarianten

Info

Publication number
DE60202478D1
DE60202478D1 DE60202478T DE60202478T DE60202478D1 DE 60202478 D1 DE60202478 D1 DE 60202478D1 DE 60202478 T DE60202478 T DE 60202478T DE 60202478 T DE60202478 T DE 60202478T DE 60202478 D1 DE60202478 D1 DE 60202478D1
Authority
DE
Germany
Prior art keywords
pcr
polynucleotides
mutated
polynucleotide variants
series
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60202478T
Other languages
English (en)
Other versions
DE60202478T2 (de
DE60202478T3 (de
Inventor
Ary Bovenberg
Richard Kerkman
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
DSM IP Assets BV
Original Assignee
DSM IP Assets BV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26076965&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE60202478(D1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by DSM IP Assets BV filed Critical DSM IP Assets BV
Application granted granted Critical
Publication of DE60202478D1 publication Critical patent/DE60202478D1/de
Publication of DE60202478T2 publication Critical patent/DE60202478T2/de
Publication of DE60202478T3 publication Critical patent/DE60202478T3/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/78—Hydrolases (3) acting on carbon to nitrogen bonds other than peptide bonds (3.5)
    • C12N9/80—Hydrolases (3) acting on carbon to nitrogen bonds other than peptide bonds (3.5) acting on amide bonds in linear amides (3.5.1)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/102—Mutagenizing nucleic acids
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/102—Mutagenizing nucleic acids
    • C12N15/1027—Mutagenizing nucleic acids by DNA shuffling, e.g. RSR, STEP, RPR
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/102—Mutagenizing nucleic acids
    • C12N15/1031—Mutagenizing nucleic acids mutagenesis by gene assembly, e.g. assembly by oligonucleotide extension PCR
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P13/00—Preparation of nitrogen-containing organic compounds
    • C12P13/04—Alpha- or beta- amino acids
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P41/00—Processes using enzymes or microorganisms to separate optical isomers from a racemic mixture
    • C12P41/006—Processes using enzymes or microorganisms to separate optical isomers from a racemic mixture by reactions involving C-N bonds, e.g. nitriles, amides, hydantoins, carbamates, lactames, transamination reactions, or keto group formation from racemic mixtures

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Analytical Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Saccharide Compounds (AREA)
DE60202478T 2001-07-23 2002-07-23 Verfahren zur herstellung von polynukleotidvarianten Expired - Lifetime DE60202478T3 (de)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
EP01202821 2001-07-23
EP01202821 2001-07-23
EP01203457 2001-09-11
EP01203457 2001-09-11
PCT/EP2002/008225 WO2003010183A2 (en) 2001-07-23 2002-07-23 Process for preparing variant polynucleotides

Publications (3)

Publication Number Publication Date
DE60202478D1 true DE60202478D1 (de) 2005-02-03
DE60202478T2 DE60202478T2 (de) 2005-12-29
DE60202478T3 DE60202478T3 (de) 2010-01-07

Family

ID=26076965

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60202478T Expired - Lifetime DE60202478T3 (de) 2001-07-23 2002-07-23 Verfahren zur herstellung von polynukleotidvarianten

Country Status (7)

Country Link
US (1) US7402383B2 (de)
EP (1) EP1409667B2 (de)
AT (1) ATE286124T1 (de)
AU (1) AU2002333269A1 (de)
DE (1) DE60202478T3 (de)
DK (1) DK1409667T4 (de)
WO (1) WO2003010183A2 (de)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7402383B2 (en) 2001-07-23 2008-07-22 Dsm Ip Assets B.V. Process for preparing variant polynucleotides
EP2123772A1 (de) 2008-04-29 2009-11-25 DSM IP Assets B.V. Beta-Lactamantibiotikum produzierende Stämme
EP2123768A1 (de) 2008-05-20 2009-11-25 DSM IP Assets B.V. Herstellung von (Z)-6,7-Dihydro-1H-azepin-2(5H)-on
EP2123767A1 (de) 2008-05-20 2009-11-25 DSM IP Assets B.V. Herstellung von Epsilon-Caprolactam mittels Lysinzyklisierung
EP2130918A1 (de) * 2008-06-05 2009-12-09 C-Lecta GmbH Verfahren zur Erzeugung einer Varianten-Bibliothek von DNA-Sequenzen
US20090312196A1 (en) * 2008-06-13 2009-12-17 Codexis, Inc. Method of synthesizing polynucleotide variants
US8383346B2 (en) 2008-06-13 2013-02-26 Codexis, Inc. Combined automated parallel synthesis of polynucleotide variants
WO2010015627A2 (en) 2008-08-05 2010-02-11 Dsm Ip Assets B.V. Adipoyl-7-adca producing strains
AU2010221862A1 (en) 2009-03-11 2011-10-06 Dsm Ip Assets B.V. Preparation of alpha-ketopimelic acid
CA2758396C (en) 2009-04-24 2018-06-12 Dsm Ip Assets B.V. Carbohydrate degrading polypeptide and uses thereof
CA2787719A1 (en) 2010-02-11 2011-08-18 Dsm Ip Assets B.V. Polypeptide having cellobiohydrolase activity and uses thereof
US9175050B2 (en) 2010-06-29 2015-11-03 Dsm Ip Assets B.V. Polypeptide having swollenin activity and uses thereof
BR112012033703A2 (pt) 2010-06-29 2016-10-11 Dsm Ip Assets Bv polipeptídeo tendo atividade beta-glicosidase e seus usos
AU2011273689B2 (en) 2010-06-29 2014-08-21 Dsm Ip Assets B.V. Polypeptide having carbohydrate degrading activity and uses thereof
CN102971419B (zh) 2010-06-29 2015-02-11 帝斯曼知识产权资产管理有限公司 具有降解碳水化合物材料的活性或帮助降解碳水化合物材料的活性的多肽及其用途
CA2803513A1 (en) 2010-06-29 2012-01-05 Margot Elisabeth Francoise Schooneveld-Bergmans Polypeptide having acetyl xylan esterase activity and uses thereof
BR112012033699A2 (pt) 2010-06-29 2016-10-11 Dsm Ip Assets Bv polipeptídeo tendo atividade beta-glicosidase e seus usos
WO2012031910A2 (en) 2010-09-10 2012-03-15 Dsm Ip Assets B.V. Method for preparing alpha-ketopimelic acid by c1-elongation
EP3444338A1 (de) 2012-01-23 2019-02-20 DSM IP Assets B.V. Herstellung von diterpen
DK3202900T3 (en) 2013-02-04 2019-04-08 Dsm Ip Assets Bv CARBOHYDRATE DEGRADING POLYPEPTIDE AND APPLICATIONS THEREOF
AU2014273055A1 (en) 2013-05-31 2015-12-17 Dsm Ip Assets B.V. Microorganisms for diterpene production
WO2014202620A2 (en) 2013-06-19 2014-12-24 Dsm Ip Assets B.V. Rasamsonia gene and use thereof
WO2014202624A2 (en) 2013-06-19 2014-12-24 Dsm Ip Assets B.V. Rasamsonia gene and use thereof
WO2014202622A2 (en) 2013-06-19 2014-12-24 Dsm Ip Assets B.V. Rasamsonia gene and use thereof
WO2014202621A1 (en) 2013-06-20 2014-12-24 Dsm Ip Assets B.V. Carbohydrate degrading polypeptide and uses thereof
EP3021689B1 (de) 2013-07-15 2021-03-24 DSM IP Assets B.V. Herstellung von diterpen
US20160185813A1 (en) 2013-07-31 2016-06-30 Dsm Ip Assets B.V. Recovery of steviol glycosides
CA3025596A1 (en) 2016-06-10 2017-12-14 Dsm Ip Assets B.V. Mutant lipase and use thereof
WO2019213624A1 (en) * 2018-05-04 2019-11-07 The Regents Of The University Of California Spiked primers for enrichment of pathogen nucleic acids among background of nucleic acids
CA3100611A1 (en) 2018-05-18 2019-11-21 Dsm Ip Assets B.V. Mutant lipase and use thereof
WO2019219904A2 (en) 2018-05-18 2019-11-21 Dsm Ip Assets B.V. Mutant lipase and use thereof
CN109750032A (zh) * 2019-02-28 2019-05-14 尚科生物医药（上海）有限公司 一种构建基因多点突变和进化的方法
EP3766982A1 (de) 2019-07-18 2021-01-20 Delft Advanced Biofuels B.V. Integriertes system zur biokatalytischen herstellung und rückgewinnung einer organischen substanz
AU2021367159A1 (en) 2020-10-22 2023-05-04 Cargill, Incorporated Microorganisms for diterpene production

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5605793A (en) 1994-02-17 1997-02-25 Affymax Technologies N.V. Methods for in vitro recombination
JP4156666B2 (ja) 1995-08-11 2008-09-24 ノボザイムス アクティーゼルスカブ ポリペプチド変異体を調整するための方法
US5965408A (en) 1996-07-09 1999-10-12 Diversa Corporation Method of DNA reassembly by interrupting synthesis
EP0906420A1 (de) * 1996-06-07 1999-04-07 Massachusetts Institute Of Technology Programmiertem regelmässige mutagenese
DK1717322T3 (da) 1997-01-17 2012-10-22 Codexis Mayflower Holdings Llc Udvikling af hele celler og organismer ved rekursiv sekvensrekombination
AU738461B2 (en) 1997-03-18 2001-09-20 Novozymes A/S Shuffling of heterologous DNA sequences
US6153410A (en) * 1997-03-25 2000-11-28 California Institute Of Technology Recombination of polynucleotide sequences using random or defined primers
GB9712512D0 (en) * 1997-06-16 1997-08-20 Bioinvent Int Ab A method for in vitro molecular evolution of protein function
US6767701B1 (en) * 1998-10-26 2004-07-27 Novozymes A/S Methods of constructing and screening a DNA library of interest in filamentous fungal cells
AU3210100A (en) * 1999-01-19 2000-08-01 Maxygen, Inc. Methods for making character strings, polynucleotides and polypeptides having desired characteristics
WO2001029212A1 (en) 1999-10-19 2001-04-26 Enchira Biotechnology Corporation Methods for chimeragenesis of whole genomes or large polynucleotides
US7402383B2 (en) 2001-07-23 2008-07-22 Dsm Ip Assets B.V. Process for preparing variant polynucleotides
US20050130140A1 (en) 2001-07-23 2005-06-16 Bovenberg Roelof A.L. Process for preparing variant polynucleotides

Also Published As

Publication number Publication date
US7402383B2 (en) 2008-07-22
DE60202478T2 (de) 2005-12-29
EP1409667A2 (de) 2004-04-21
EP1409667B1 (de) 2004-12-29
WO2003010183A2 (en) 2003-02-06
US20050130141A1 (en) 2005-06-16
AU2002333269A1 (en) 2003-02-17
DE60202478T3 (de) 2010-01-07
EP1409667B2 (de) 2009-06-10
ATE286124T1 (de) 2005-01-15
DK1409667T4 (da) 2009-09-07
DK1409667T3 (da) 2005-04-25
WO2003010183A3 (en) 2003-11-13

Similar Documents

Publication Publication Date Title
ATE286124T1 (de) Verfahren zur herstellung von polynukleotidvarianten
ATE269908T1 (de) Methode zur sequenzierung von nukleinsäuren
DE69636080D1 (de) Eine in Kaskaden verlaufende Vervielfältigungsreaktion von Nukleinsäuren
PL313735A1 (en) Method of and composition for effectively sequencing nucleic acid
EP2272952B8 (de) Thermostabiler oder thermoactiver DNA-polymerase mit abgeschwächter 3'-5' Exonukleaseaktivität
DE69534855D1 (de) Enzymaktive dna moleküle
ATE205878T1 (de) Verfahren zur herstellung von polynucleotiden mit erwünschten eigenschaften mittels wiederholter selektion und rekombination
NO20021223L (no) Fremgangsmater og sammensetninger for lineaer, isoterm amplifisering av polynukleotidsekvenser
SI2258847T1 (sl) Nadaljnje nove oblike molekul interferenčne RNA
WO2003033724A3 (en) Nucleic acid amplification
DE60014150D1 (de) Verfahren zur herstellung von biopolymeren mit veränderten eigenschaften
DE3883051D1 (de) Verfahren zur herstellung von stahlblechen mit guter zaehigkeit bei niedrigen temperaturen.
DE60214864D1 (de) Verfahren zur herstellung von nukleinsäuren bestehend aus stochastisch kombinierten anteilen von ausgangsnukleinsäuren
ATE431407T1 (de) Verfahren zur herstellung von dna
WO2003097834A3 (en) A method for in vitro molecular evolution of protein function
WO2002048351A3 (en) A method for in vitro molecular evolution of protein function
DE59410068D1 (de) Verfahren zur spezifischen Klonierung von Nukleinsäuren
CA2335387A1 (en) Method for analyzing phyletic lineage of scallop
WO2003100058A3 (de) Verfahren zur erzeugung von polynukleotidmolekülen
Murakami et al. Random insertion and deletion mutagenesis for construction of protein library containing nonnatural amino acids
EP1180547A3 (de) Verfahren zur DNS-Herstellung
ATE261968T1 (de) Ein verfahren zur herstellung von 2,6- dichloropurin
WO2004016757A3 (en) Methods, compositions and kits for producing nucleic and acid sequences
ATE165870T1 (de) Verfahren zur amplifizierung und/oder nachweis einer nukleinsäuresequenz, nachweisreagenz und deren verwendungen
WO2005074470A3 (en) Kits and methods for making large recombinant polynucleotides

Legal Events

Date Code Title Description
8366 Restricted maintained after opposition proceedings
8328 Change in the person/name/address of the agent

Representative=s name: DERZEIT KEIN VERTRETER BESTELLT